Literature DB >> 20124561

Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets.

Camilla I Svensson1, Ernst Brodin.   

Abstract

The treatment of chronic inflammatory and neuropathic pain is a major concern, and the need for new more effective analgesics with less adverse effects is immense. Traditionally, mechanisms proposed for pain modulation have centered almost exclusively on peripheral or central neurons in the pain pathways. Recent research, however, indicates that activation of microglia and astrocytes in the dorsal horn of the spinal cord is of central importance for the development of chronic pain states. Understanding the intercellular communication among astrocytes, microglia, and neurons in the dorsal horn during acute and chronic pain may be instrumental for the development of new analgesic drugs. The purpose of this review is to highlight the role of astrocytes in regulating pain processing.

Entities:  

Mesh:

Year:  2010        PMID: 20124561     DOI: 10.1124/mi.10.1.6

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  29 in total

1.  Spinal astrocytes produce and secrete dynorphin neuropeptides.

Authors:  Andrew Wahlert; Lydiane Funkelstein; Bethany Fitzsimmons; Tony Yaksh; Vivian Hook
Journal:  Neuropeptides       Date:  2013-01-03       Impact factor: 3.286

2.  Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients.

Authors:  Yuqiang Shi; Benjamin B Gelman; Joshua G Lisinicchia; Shao-Jun Tang
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

3.  PPARγ activation blocks development and reduces established neuropathic pain in rats.

Authors:  J Morgenweck; R B Griggs; R R Donahue; J E Zadina; B K Taylor
Journal:  Neuropharmacology       Date:  2013-02-13       Impact factor: 5.250

Review 4.  Targeting astrocyte signaling for chronic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

5.  Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain.

Authors:  Matthew S Alkaitis; Carlos Solorzano; Russell P Landry; Daniele Piomelli; Joyce A DeLeo; E Alfonso Romero-Sandoval
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

6.  Spinal cord stimulation reduces mechanical hyperalgesia and glial cell activation in animals with neuropathic pain.

Authors:  Karina L Sato; Lisa M Johanek; Luciana S Sanada; Kathleen A Sluka
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

Review 7.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

8.  Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1β and ERK signaling in the spinal cord of mice.

Authors:  T Berta; Y-C Liu; Z-Z Xu; R-R Ji
Journal:  Neuroscience       Date:  2013-05-21       Impact factor: 3.590

9.  Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.

Authors:  Seo-Yeon Yoon; Caleb R Robinson; Haijun Zhang; Patrick M Dougherty
Journal:  J Pain       Date:  2013-02       Impact factor: 5.820

10.  Intrathecal Injection of Human Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorates Neuropathic Pain in Rats.

Authors:  Chunxiu Chen; Fengfeng Chen; Chengye Yao; Shaofang Shu; Juan Feng; Xiaoling Hu; Quan Hai; Shanglong Yao; Xiangdong Chen
Journal:  Neurochem Res       Date:  2016-09-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.